Tara Pande

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Lei S. Qi, D. Endy, N. Heaton, 2020, Cell.

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

Drew Endy, Xueqiu Lin, David B. Lewis, 2020, bioRxiv.

A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses

Lei S. Qi, Xueqiu Lin, Yanxia Liu, 2021, Cell Reports Medicine.